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a,-Adrenergic activation of isolated brown adipocytes causes a rapid mobilization of intracellular Ca*+. The 
cells also respond with an increased turnover of inositol lipids. The present work demonstrates that CL,- 
adrenergic stimulation of brown adipocytes results in phospholipase C-mediated breakdown of phosphatid- 
ylinositol bisphosphate to form inositol trisphosphate. The rate of appearance of inositol trisphosphate is 
sufficiently rapid for it to mediate or contribute to Ca*+ mobilization in these cells. 
(Brown adipocyte) qddrenoceptor Inositol polyphosphate Li+ 
1. INTRODUCTION 
Previous studies have shown that crr-adreno- 
ceptor activation causes mobilization of in- 
tracellular Ca2+ in brown adipocytes [l]. This 
cYr-adrenergic effect is dependent on the presence 
of extracellular Na+ [ 1] and may be associated with 
an increased Na+ influx. Since the abundant 
mitochondria in brown adipocytes possess an ac- 
tive Na+/Ca2+ exchange mechanism [2], it has 
been suggested that the cYr-adrenoceptor-induced 
Ca2+ mobilization could arise secondarily to Na+ 
entry [1,3,4]. 
ai-Adrenergic stimulation of brown adipocytes 
also induces an increased turnover of PtdIns [5,6]. 
It is generally believed that agonist-activated 
turnover of PtdIns reflects phospholipase C- 
mediated breakdown of phosphatidylinositol 
4,5bisphosphate to diacylglycerol and inositol 
1,4,5trisphosphate [Ins(l,4,5)P3]. Ins(l,4,5)P3 
has been shown to cause Ca2+ release in several dif- 
ferent types of permeabilized cells [7-91 and from 
microsomal fractions from hepatocytes [IO] and 
Abbreviations: InsP3, inositol trisphosphate; PtdIns. 
phosphatidylinositol 
insulinoma cells [ 111. Ins( 1,4,5)P3 also caused 
EGTA-inhibited activation of pyruvate dehydro- 
genase in isolated white fat cells [ 121, which may be 
indicative of intracellular Ca2+ release. 
The aim of this work was to determine whether 
q-adrenergic activation of brown adipocytes 
results in an increase in cellular Ins(1,4,5)P3, in the 
light of the possibility that this putative messenger 
could contribute to Ca2+ mobilization in these 
cells. 
2. MATERIALS AND METHODS 
2.1. Isolation of brown adipocytes 
Brown adipocytes were isolated by collagenase 
digestion of tissue obtained from adult golden 
hamsters, as described [l]. Cell viability was 
routinely about 90070, estimated by staining with 
Alcian blue. 
2.2. Incubation of brown adipocytes and labelling 
of inositol lipids 
All incubations were performed in Krebs-Ringer 
bicarbonate buffer containing 2% bovine serum 
albumin, 10 mM glucose and 10 mM fructose at 
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pH 7.4 (37°C) and under a gas phase of 5% CO2 
in 02 (pH was continuously monitored with phenol 
red). Inositol lipids were labelled by incubating the 
adipocytes (1 .O x lo6 cells/ml) for 90 min in 
medium containing 10 &i/ml myo-[3H]inositol. 
Extracellular radioactivity was removed by cen- 
trifugation and the cells were incubated for an ad- 
ditional 20 min at 0.5 x lo6 cells/ml. 1 /IM pro- 
pranolol was added and the suspension divided in- 
to aliquots for experimental incubations. To some 
of the aliquots drugs were added. 1 ml samples 
were taken from these incubations, and the reac- 
tions stopped by precipitation with 2 ml of 4.5% 
perchloric acid. Perchloric acid was added to con- 
trols (t = 0) prior to the addition of drugs. The 
samples were left on ice for 10 min and then cen- 
trifuged. The supernatants were neutralized with 
3 ml of 0.5 M KOH/9 mM NazB407 (pH 8). 
Representative aliquots were extracted with 
chloroform-methanol to determine total radioac- 
tivity in cellular phospholipids [ 131. 
2.3. Separation of inositol phosphates 
The water-soluble inositol phosphates were 
separated by anion-exchange chromatography on 
Dowex-AGl as described by Berridge et al. [14]. 
Radioactivity in fractions corresponding to ino- 
sitol phosphate (InsP), inositol bisphosphate 
(InsPz) and InsP3 were determined and expressed 
as a percentage of the radioactivity in total lipids, 
or as a percentage of control (t = 0) radioactivity. 
2.4. Materials 
myo-[3H]Inositol was obtained from American 
Radiochemicals, Dowex-AGl from Bio-Rad, 
norepinephrine bitartrate, propranolol-HCl and 
yohimbine-HCl from Sigma. Prazosin-HCI was a 
gift from Pfizer. 
3. RESULTS AND DISCUSSION 
Norepinephrine (10 PM) caused a modest, but 
statistically significant increase in [3H]InsP3 1 min 
after its addition (P < 0.05; n = 5); data are shown 
in fig.1. Also shown are the effects of 
norepinephrine when 20 mM LiCl [15] was present 
20 min prior to, and during, stimulation. Li+ did 
not affect the basal or initial (1 min) increase in 
InsP3, but markedly potentiated the increase in 
InsPs level 5 and 10 min after the addition of 
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Fig.1. Effect of Li+ on basal and agonist-stimulated 
levels of InsP3 in brown adipocytes. [3H]Inositol-loaded 
cells were resuspended in fresh buffer and incubated 
with or without 20 mM LiCl for 20 min (controls 
received 20 mM NaCl). At 20 min, 1 PM propranolol 
followed by lO,eM norepinephrine were added and the 
incubation continued for another 10 min. (o) - Li+, 
( n ) + Li+. The radioactivity in the InsPs fraction is here 
calculated as ‘70 of the cpm in the total phospholipid 
fraction. Points shown are means from 3 parallel 
experiments (k SE). (*) and (**) show significant 
increases above the pre-norepinephrine level at 20 min 
(P < 0.05 and c 0.01, respectively); + shows significant 
effect of Li (P < 0.05); Student’s paired t-test. 
norepinephrine. A similar effect was noted for 
InsPz and InsP, but for InsP the relative changes 
due to hormone or Li+ were much smaller (not 
shown; cf. fig.2). This concentration of Li+ did 
not affect cell viability and only slightly (% 10%) 
suppressed the norepinephrine-induced respiratory 
response (this response is mainly a&adrenergic ef- 
fect but the slight suppression was sustained when 
the cui-adrenergic component of respiration was in- 
hibited by prazosin; thus it was not due to a selec- 
tive inhibition of the cyr-component). 
In the experiments, 1 FM propranolol was 
routinely added to diminish the oxygen consump- 
tion of the cells and thus ensure an adequate ox- 
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ygen supply. Garcia-Sainz et al. [5,16] have 
reported an increased incorporation of 32P into 
PtdIns in the presence of a high concentration of 
propranolol. This is probably due to inhibition of 
phosphatidic acid phosphohydrolase; however, in 
prelimin~y experiments (not shown), 1 gM pro- 
pranolol did not affect the incorporation of [3H]- 
inositol into inositol phosphates in this system. 
Fig.2 shows the time course of the effect of 
10&M norepinephrine, in the presence of 20 mM 
Li+, on [3H]InsP3, t3H]InsP2 and [3H]InsP levels 
in brown adipocytes. Changes in InsP levels were, 
relative to the control level, smaller than for InsP2 
and InsP3 and thus statistically less reliable (note 
the difference in ordinate scales). Norepinephrine 
induced an increase in both InsPz and InsP3 
already at the earliest time point examined, 15 s. 
This indicates that pol~hosphoinositide hydro- 
lysis may initiate inositol lipid cycling in brown 
adipocytes and that earlier reports on increased 
PtdIns synthesis being stimulated by a-adrenergic 
activation [5,6] may be understood as a resynthesis 
after polyphosphoinositide breakdown, as shown 
for a number of other cell systems 117,181. The 
increases in both InsP2 and InsP3 were unaffect- 
ed by the arz-adrenoceptor antagonist yohimbine 
(0.1 ,uM) but were completely blocked by the 
rut-adrenoceptor antagonist, prazosin, at the same 
concentration. This result is consistent with the 
reported findings of Garcia-Sainz et al. [5] and of 
Mohell et al. [6] who showed that prazosin was a 
much more potent blocker than yohimbine of the 
phenylephrine-stimulated PtdIns turnover. The in- 
crease in InsP3 is at least as rapid as the previously 
described cri-adrenergic Ca2+ mobilization in these 
cells [l], suggesting that release of Ca” by InsP3 
could well contribute to this response. 
One problem in relating levels of InsP3 as deter- 
mined by anion exchange to biological responses is 
the recent finding that the tritiated material 
formed ir. some cells is a mixture of isomers, 
specifically Ins( 1,4,5)Ps and Ins( 1,3,4)P3 [ 19, 
20,221. In different systems, Ins(1,4,5)P3 has 
been shown to release intracellular Ca2+ [17]. 
While Ins(1,3,4)P3 has not been tested directly, 
there is indirect evidence that it does not mobilize 
Ca2+ 1201. In the present study, j3H]InsP3 was not 
resolved into the 2 isomers. There are interesting 
parallels, however, between these data and those 
of Burgess et al. [20] and Rubin [21] with liver and 
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Fig.2 Effect of norepinephrine on the formation of 
inositol phosphates in brown adipocytes. [31-I]Inositol- 
loaded cells were preincubated for 20 min in the 
presence of 20 mM LiCI. At 20 min, 1 pM propranolol 
was added and after another minute, 0.1 FM prazosin, 
0.1 ,&I yohimbine or buffer. Immediately thereafter 
1OpM norepinephrine was added. The amount of 
[‘H]inositol phosphates was measured and is presented 
as crlo f control values (100% thus corresponds to the 
level of the inositol phosphates in the batch, before the 
additions). The data represent mean values from 3 
experiments; bars indicate * SE. Observe that the scale 
is adjusted so that the absolute amount of cpm is 
identical for all 3 panels (mean % of total phosphoIipid 
label was 28.7,0.72, and 0.28 for InsP, InsPz and InsPs, 
respectively). 
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exocrine pancreas which permit some speculation 
on the isomers formed. In the pancreas, as for the 
brown fat cells, Li+ potentiates [3H]InsP3 ac- 
cumulation. In pancreas, this potentiation occurs 
after 2 min of stimulation [21] and is totally ac- 
counted for by the Ins(1,3,4)P3 isomer, Ins 
(1,4,5)P3 not being affected by Li + at all [20]. 
This finding is consistent with reports that during 
the initial minute after receptor activation, only 
the Ins(1,4,5)P3 isomer is increased [20,22]. Thus, 
the pattern of [3H]InsP3 production in the brown 
adipocyte would suggest hat the initial increase, in 
the first minute or so, is largely Ins( 1,4,5)Ps, while 
the Li+-sensitive material which accumulates with 
more prolonged stimulation may be primarily 
Ins(l,3,4)P~. Studies are currently under way to ex- 
amine more directly these isomers in the brown 
adipocyte system. 
In summary, these results demonstrate that in- 
ositol lipid turnover in the brown adipocyte results 
from an ai-adrenoceptor-mediated phospho- 
diesteratic breakdown of polyphosphoinositides, 
liberating soluble inositol phosphates. The forma- 
tion of InsP3 is rapid enough to enable it to con- 
tribute to the previously described intracellular 
Ca*” mobilization in these cells. 
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